Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE vs EPINASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENZALUTAMIDE vs EPINASTINE: Safety Overview

Metric ENZALUTAMIDE EPINASTINE
Total FAERS Reports 49,270 843
Deaths Reported 9,676 6
Death Rate 19.6% 0.7%
Hospitalizations 9,282 25
Average Patient Age 76.0 yrs 50.0 yrs
% Female Patients 0.6% 66.9%
FDA Approval Date Apr 22, 2022 Dec 7, 2016
Manufacturer Astellas Pharma US, Inc. Somerset Therapeutics, LLC
Route ORAL OPHTHALMIC
Marketing Status Prescription Discontinued